T 1404/21 (Solid compositions of a GLP-1 agonist / NOVO NORDISK) of 26.06.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T140421.20240626
- Date of decision
- 26 June 2024
- Case number
- T 1404/21
- Online on
- 11 September 2024
- Petition for review of
- -
- Application number
- 11805824.7
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID
- Applicant name
- Novo Nordisk A/S
- Opponent name
- Generics (U.K.) Limited
Hexal AG
Galenicum Health S.L.U. - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(b)European Patent Convention Art 83European Patent Convention Art 100(a)European Patent Convention Art 56
- Keywords
- Grounds for opposition - insufficiency of disclosure (no)
Grounds for opposition - lack of inventive step (no) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeals are dismissed.